These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 25063808)
1. Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling. Zhang D; Tong X; Arthurs B; Guha A; Rui L; Kamath A; Inoki K; Yin L J Biol Chem; 2014 Sep; 289(37):25925-35. PubMed ID: 25063808 [TBL] [Abstract][Full Text] [Related]
2. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878 [TBL] [Abstract][Full Text] [Related]
3. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609 [TBL] [Abstract][Full Text] [Related]
4. The hepatic BMAL1/AKT/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPARα pathway. Zhang D; Tong X; Nelson BB; Jin E; Sit J; Charney N; Yang M; Omary MB; Yin L Hepatology; 2018 Sep; 68(3):883-896. PubMed ID: 29534306 [TBL] [Abstract][Full Text] [Related]
5. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Zhang C; Wendel AA; Keogh MR; Harris TE; Chen J; Coleman RA Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1667-72. PubMed ID: 22307628 [TBL] [Abstract][Full Text] [Related]
6. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D Nat Med; 2013 Aug; 19(8):1054-60. PubMed ID: 23832089 [TBL] [Abstract][Full Text] [Related]
8. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition. Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307 [TBL] [Abstract][Full Text] [Related]
9. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Titchenell PM; Quinn WJ; Lu M; Chu Q; Lu W; Li C; Chen H; Monks BR; Chen J; Rabinowitz JD; Birnbaum MJ Cell Metab; 2016 Jun; 23(6):1154-1166. PubMed ID: 27238637 [TBL] [Abstract][Full Text] [Related]
10. Nobiletin Protects Against Alcoholic Liver Disease in Mice via the BMAL1-AKT-Lipogenesis Pathway. Li X; Zhuang R; Zhang K; Zhang Y; Lu Z; Wu F; Wu X; Li W; Zhang Z; Zhang H; Zhu W; Zhang B Mol Nutr Food Res; 2024 Jun; 68(12):e2300833. PubMed ID: 38850176 [TBL] [Abstract][Full Text] [Related]
11. Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway. Tan SH; Shui G; Zhou J; Shi Y; Huang J; Xia D; Wenk MR; Shen HM Autophagy; 2014 Feb; 10(2):226-42. PubMed ID: 24296537 [TBL] [Abstract][Full Text] [Related]
12. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110 [TBL] [Abstract][Full Text] [Related]
13. Nobiletin protects against insulin resistance and disorders of lipid metabolism by reprogramming of circadian clock in hepatocytes. Qi G; Guo R; Tian H; Li L; Liu H; Mi Y; Liu X Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):549-562. PubMed ID: 29501626 [TBL] [Abstract][Full Text] [Related]
14. Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling. Tao R; Xiong X; Liangpunsakul S; Dong XC Diabetes; 2015 Apr; 64(4):1211-23. PubMed ID: 25377878 [TBL] [Abstract][Full Text] [Related]
15. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773 [TBL] [Abstract][Full Text] [Related]
16. Bmal1 interference impairs hormone synthesis and promotes apoptosis in porcine granulosa cells. Wang W; Yin L; Bai L; Ma G; Zhao C; Xiang A; Pang W; Yang G; Chu G Theriogenology; 2017 Sep; 99():63-68. PubMed ID: 28708501 [TBL] [Abstract][Full Text] [Related]
17. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
18. Insulin post-transcriptionally modulates Bmal1 protein to affect the hepatic circadian clock. Dang F; Sun X; Ma X; Wu R; Zhang D; Chen Y; Xu Q; Wu Y; Liu Y Nat Commun; 2016 Aug; 7():12696. PubMed ID: 27576939 [TBL] [Abstract][Full Text] [Related]